Park Medi World IPO opens for subscription from December 10 to December 12, 2025, with allotment on December 15 and listing on BSE and NSE on December 17, 2025. The issue size totals ₹920 crore, comprising a fresh issue of ₹770 crore and an offer for sale of ₹150 crore. Park Medi World operates as one of North India’s largest private hospital chains with 3,000 beds across multiple facilities, specializing in critical care, surgery, and diagnostics. The Park Medi World IPO offers investors exposure to India’s healthcare growth driven by rising demand, insurance penetration, and infrastructure expansion.
₹5
₹162
₹
Expert Opinions
Market sentiment for Park Medi World IPO is positive, fueled by strong demand for quality healthcare infrastructure amid India’s rising medical needs. Company strengths include a large 3,000-bed network across North India, specialized critical care and surgical capabilities, and established brand recognition with experienced leadership. Risks and challenges involve high capex requirements, regulatory compliance pressures, doctor retention issues, and regional competition intensity.
Valuation analysis of Park Medi World IPO in 2025 reveals a Return on Equity (ROE) of 20.68%, ROCE of 17.47%, and Net Asset Value (NAV) of ₹26.58, indicating solid returns with moderate asset efficiency. Long-term investment perspective is attractive given healthcare sector tailwinds from insurance growth, aging population, and medical tourism, though execution on bed utilization and cost control remains crucial.
Investor Considerations
Park Medi World IPO investors should evaluate the company’s strong fundamentals, with revenue up 13% to ₹1,425.97 crore and PAT rising 40% to ₹213.22 crore in FY 2025, supported by 26.11% EBITDA margins. The healthcare sector outlook is robust, driven by increasing insurance penetration, medical tourism, and demand for quality hospital infrastructure.
Valuation analysis for Park Medi World IPO in 2025 shows a Price to Book Value of 6.09, PAT Margin of 15.30%, and Debt/Equity ratio of 0.61, indicating premium pricing with solid profitability and manageable leverage. Growth prospects include bed expansion, new hospital development, and equipment upgrades using IPO proceeds. Risks involve high capex needs, regulatory changes, doctor retention, and regional competition. Long-term investors may benefit from healthcare tailwinds, while short-term goals face execution and market volatility.
| Date | GMP | Trend |
|---|---|---|
| 14 Dec 2025 14.16 | ₹5 | --- |
| 13 Dec 2025 19.14 | ₹5 | --- |
| 12 Dec 2025 19.28 | ₹5 | Down |
| 11 Dec 2025 19.03 | ₹10 | Down |
| 10 Dec 2025 20.05 | ₹25 | --- |
FAQs
Park Medi World IPO Current GMP is ₹5.
Park Medi World IPO Expected Returns is 3.09%.
Park Medi World IPO estimated listing price is ₹167.